Ulrike Glaenzel

495 total citations
10 papers, 334 citations indexed

About

Ulrike Glaenzel is a scholar working on Oncology, Molecular Biology and Pharmacology. According to data from OpenAlex, Ulrike Glaenzel has authored 10 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 2 papers in Pharmacology. Recurrent topics in Ulrike Glaenzel's work include Colorectal Cancer Treatments and Studies (2 papers), Inflammatory mediators and NSAID effects (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Ulrike Glaenzel is often cited by papers focused on Colorectal Cancer Treatments and Studies (2 papers), Inflammatory mediators and NSAID effects (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Ulrike Glaenzel collaborates with scholars based in Switzerland, United States and France. Ulrike Glaenzel's co-authors include Felix Waldmeier, Katharine Hazell, Peter End, Yi Jin, Steve Warrington, John B. Porter, B. Wirz, Gerard Bruin, Romain Séchaud and Jessica Valencia and has published in prestigious journals such as Drug Metabolism and Disposition, European Journal of Pharmaceutical Sciences and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Ulrike Glaenzel

10 papers receiving 321 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrike Glaenzel Switzerland 8 95 81 71 70 58 10 334
Joe Murphy United States 6 99 1.0× 182 2.2× 89 1.3× 32 0.5× 82 1.4× 8 395
Naoaki Murao Japan 15 205 2.2× 68 0.8× 24 0.3× 59 0.8× 97 1.7× 26 624
Upendra Marathi United States 10 144 1.5× 33 0.4× 157 2.2× 27 0.4× 21 0.4× 15 467
Nora Anderson United States 5 265 2.8× 36 0.4× 26 0.4× 94 1.3× 97 1.7× 8 601
Hassan A. Hamali Saudi Arabia 9 202 2.1× 60 0.7× 38 0.5× 19 0.3× 135 2.3× 41 526
Yasuhiro Sato Japan 10 102 1.1× 33 0.4× 20 0.3× 23 0.3× 61 1.1× 27 510
Yvonne Pak United States 12 143 1.5× 108 1.3× 74 1.0× 15 0.2× 148 2.6× 17 534
Ashit Trivedi United States 9 114 1.2× 29 0.4× 53 0.7× 20 0.3× 17 0.3× 29 316
Liuh Ling Goh Singapore 11 80 0.8× 40 0.5× 35 0.5× 17 0.2× 10 0.2× 28 299

Countries citing papers authored by Ulrike Glaenzel

Since Specialization
Citations

This map shows the geographic impact of Ulrike Glaenzel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Glaenzel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Glaenzel more than expected).

Fields of papers citing papers by Ulrike Glaenzel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Glaenzel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Glaenzel. The network helps show where Ulrike Glaenzel may publish in the future.

Co-authorship network of co-authors of Ulrike Glaenzel

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Glaenzel. A scholar is included among the top collaborators of Ulrike Glaenzel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Glaenzel. Ulrike Glaenzel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Glaenzel, Ulrike, et al.. (2024). Absorption, Distribution, Metabolism, and Excretion of Icenticaftor (QBW251) in Healthy Male Volunteers at Steady State and In Vitro Phenotyping of Major Metabolites. Drug Metabolism and Disposition. 52(12). 1379–1387. 2 indexed citations
2.
Glaenzel, Ulrike, Yi Jin, Kirsten Schroer, et al.. (2020). Absorption, Distribution, Metabolism, and Excretion of Capmatinib (INC280) in Healthy Male Volunteers and In Vitro Aldehyde Oxidase Phenotyping of the Major Metabolite. Drug Metabolism and Disposition. 48(10). 873–885. 31 indexed citations
3.
Schiller, Hilmar, Yi Jin, Ad F. Roffel, et al.. (2020). An integrated assessment of the ADME properties of the CDK4/6 Inhibitor ribociclib utilizing preclinical in vitro, in vivo, and human ADME data. Pharmacology Research & Perspectives. 8(3). e00599–e00599. 18 indexed citations
4.
5.
Pearson, David, H. Weiss, Yi Jin, et al.. (2017). Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro. Drug Metabolism and Disposition. 45(7). 817–825. 16 indexed citations
6.
Blumenstein, Lars, Ulrike Glaenzel, Yi Jin, et al.. (2015). Absorption, distribution, metabolism, and excretion of [14C]BYL719 (alpelisib) in healthy male volunteers. Cancer Chemotherapy and Pharmacology. 76(4). 751–760. 30 indexed citations
7.
Gschwind, Hans-Peter, Ulrike Glaenzel, Felix Waldmeier, et al.. (2012). Metabolism and disposition of the oral absorption enhancer 14C-radiolabeled 8-(N-2-hydroxy-5-chlorobenzoyl)-amino-caprylic acid (5-CNAC) in healthy postmenopausal women and supplementary investigations in vitro. European Journal of Pharmaceutical Sciences. 47(1). 44–55. 5 indexed citations
8.
Waldmeier, Felix, Gerard Bruin, Ulrike Glaenzel, et al.. (2010). Pharmacokinetics, Metabolism, and Disposition of Deferasirox in β-Thalassemic Patients with Transfusion-Dependent Iron Overload Who Are at Pharmacokinetic Steady State. Drug Metabolism and Disposition. 38(5). 808–816. 76 indexed citations
9.
Waldmeier, Felix, Ulrike Glaenzel, B. Wirz, et al.. (2007). Absorption, Distribution, Metabolism, and Elimination of the Direct Renin Inhibitor Aliskiren in Healthy Volunteers. Drug Metabolism and Disposition. 35(8). 1418–1428. 104 indexed citations
10.
Zollinger, Markus, Felix Waldmeier, Stefan Hartmann, et al.. (2006). PIMECROLIMUS: ABSORPTION, DISTRIBUTION, METABOLISM, AND EXCRETION IN HEALTHY VOLUNTEERS AFTER A SINGLE ORAL DOSE AND SUPPLEMENTARY INVESTIGATIONS IN VITRO. Drug Metabolism and Disposition. 34(5). 765–774. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joe Murphy Breakdown of academic impact, for papers by Naoaki Murao Breakdown of academic impact, for papers by Upendra Marathi Breakdown of academic impact, for papers by Nora Anderson Breakdown of academic impact, for papers by Hassan A. Hamali Breakdown of academic impact, for papers by Yasuhiro Sato Breakdown of academic impact, for papers by Yvonne Pak Breakdown of academic impact, for papers by Ashit Trivedi Breakdown of academic impact, for papers by Liuh Ling Goh
Rankless by CCL
2026